Näytetään 1 - 20 yhteensä 41 tuloksesta haulle 'Christopher D Byrne', hakuaika: 0,07s Tarkenna hakua
  1. 1
    The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease

    The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease Tekijä Erica Jennison, Christopher D. Byrne

    Julkaistu 2021-01-01
    Hae kokoteksti
    Artikkeli
  2. 2
    Noninvasive serum biomarkers for liver fibrosis in NAFLD: current and future

    Noninvasive serum biomarkers for liver fibrosis in NAFLD: current and future Tekijä Tina Reinson, Ryan M. Buchanan, Christopher D. Byrne

    Julkaistu 2023-02-01
    Hae kokoteksti
    Artikkeli
  3. 3
    Bile Acids as Emerging Players at the Intersection of Steatotic Liver Disease and Cardiovascular Diseases

    Bile Acids as Emerging Players at the Intersection of Steatotic Liver Disease and Cardiovascular Diseases Tekijä Josh Bilson, Eleonora Scorletti, Jonathan R. Swann, Christopher D. Byrne

    Julkaistu 2024-07-01
    Hae kokoteksti
    Artikkeli
  4. 4
    Higher Levels of Plasma Hyaluronic Acid and N-terminal Propeptide of Type III Procollagen Are Associated With Lower Kidney Function in Children With Non-alcoholic Fatty Liver Disease

    Higher Levels of Plasma Hyaluronic Acid and N-terminal Propeptide of Type III Procollagen Are Associated With Lower Kidney Function in Children With Non-alcoholic Fatty Liver Disea... Tekijä Antonella Mosca, Alessandro Mantovani, Annalisa Crudele, Nadia Panera, Donatella Comparcola, Rita De Vito, Marzia Bianchi, Christopher D. Byrne, Christopher D. Byrne, Giovanni Targher, Anna Alisi

    Julkaistu 2022-06-01
    Hae kokoteksti
    Artikkeli
  5. 5
    Dysregulated Neurovascular Control Underlies Declining Microvascular Functionality in People With Non-alcoholic Fatty Liver Disease (NAFLD) at Risk of Liver Fibrosis

    Dysregulated Neurovascular Control Underlies Declining Microvascular Functionality in People With Non-alcoholic Fatty Liver Disease (NAFLD) at Risk of Liver Fibrosis Tekijä Geraldine F. Clough, Andrew J. Chipperfield, Marjola Thanaj, Eleonora Scorletti, Eleonora Scorletti, Eleonora Scorletti, Philip C. Calder, Philip C. Calder, Christopher D. Byrne, Christopher D. Byrne

    Julkaistu 2020-06-01
    Hae kokoteksti
    Artikkeli
  6. 6
    Transient elastography in patients at risk of liver fibrosis in primary care: a follow-up study over 54 months

    Transient elastography in patients at risk of liver fibrosis in primary care: a follow-up study over 54 months Tekijä Tina Reinson, Christopher D Byrne, Janisha Patel, Magdy El-Gohary, Michael Moore

    Julkaistu 2021-11-01
    Hae kokoteksti
    Artikkeli
  7. 7
    Evaluation of bioelectrical impedance analysis for identifying overweight individuals at increased cardiometabolic risk: a cross-sectional study.

    Evaluation of bioelectrical impedance analysis for identifying overweight individuals at increased cardiometabolic risk: a cross-sectional study. Tekijä Maxine J E Lamb, Christopher D Byrne, James F Wilson, Sarah H Wild

    Julkaistu 2014-01-01
    Hae kokoteksti
    Artikkeli
  8. 8
    Lifestyle Interventions for Non-Obese Patients Both with, and at Risk, of Non-Alcoholic Fatty Liver Disease

    Lifestyle Interventions for Non-Obese Patients Both with, and at Risk, of Non-Alcoholic Fatty Liver Disease Tekijä Xin-Lei Zhang, Ting-Yao Wang, Giovanni Targher, Christopher D. Byrne, Ming-Hua Zheng

    Julkaistu 2022-05-01
    Hae kokoteksti
    Artikkeli
  9. 9
    Portal hypertension in nonalcoholic fatty liver disease: Challenges and perspectives

    Portal hypertension in nonalcoholic fatty liver disease: Challenges and perspectives Tekijä Lei Miao, Giovanni Targher, Christopher D. Byrne, Luca Valenti, Xiaolong Qi, Ming‐Hua Zheng

    Julkaistu 2022-06-01
    Hae kokoteksti
    Artikkeli
  10. 10
    Non-invasive fibrosis assessment in non-alcoholic fatty liver disease

    Non-invasive fibrosis assessment in non-alcoholic fatty liver disease Tekijä Rafael S. Rios, Kenneth I. Zheng, Giovanni Targher, Christopher D. Byrne, Ming-Hua Zheng, Qiang Shi

    Julkaistu 2020-11-01
    Hae kokoteksti
    Artikkeli
  11. 11
    DEPEND study protocol: early detection of patients with pancreatic cancer – a pilot study to evaluate the utility of faecal elastase-1 and 13C-mixed triglyceride breath test as screening tools in high-risk individuals

    DEPEND study protocol: early detection of patients with pancreatic cancer – a pilot study to evaluate the utility of faecal elastase-1 and 13C-mixed triglyceride breath test as scr... Tekijä Christopher D Byrne, Sam Wilding, Paul Remi Afolabi, Declan McDonnell, Victoria Goss, Jocelyn Walters, Zaed Z Hamady

    Julkaistu 2022-02-01
    Hae kokoteksti
    Artikkeli
  12. 12
    Low heart rate variability from 10-s electrocardiograms is associated with development of non-alcoholic fatty liver disease

    Low heart rate variability from 10-s electrocardiograms is associated with development of non-alcoholic fatty liver disease Tekijä In Young Choi, Yoosoo Chang, Geonggyu Kang, Hyun-Suk Jung, Hocheol Shin, Sarah H. Wild, Christopher D. Byrne, Seungho Ryu

    Julkaistu 2022-01-01
    Hae kokoteksti
    Artikkeli
  13. 13
    Decreased lung function is associated with risk of developing non-alcoholic fatty liver disease: A longitudinal cohort study.

    Decreased lung function is associated with risk of developing non-alcoholic fatty liver disease: A longitudinal cohort study. Tekijä Jae-Uk Song, Yoonjung Jang, Si-Young Lim, Seungho Ryu, Won Jun Song, Christopher D Byrne, Ki-Chul Sung

    Julkaistu 2019-01-01
    Hae kokoteksti
    Artikkeli
  14. 14
    Author Correction: Low heart rate variability from 10-s electrocardiograms is associated with development of non-alcoholic fatty liver disease

    Author Correction: Low heart rate variability from 10-s electrocardiograms is associated with development of non-alcoholic fatty liver disease Tekijä In Young Choi, Yoosoo Chang, Geonggyu Kang, Hyun-Suk Jung, Hocheol Shin, Sarah H. Wild, Christopher D. Byrne, Seungho Ryu

    Julkaistu 2022-12-01
    Hae kokoteksti
    Artikkeli
  15. 15
    Screening to identify people with type 2 diabetes at risk of liver cancer in primary care: a randomised controlled trial protocol

    Screening to identify people with type 2 diabetes at risk of liver cancer in primary care: a randomised controlled trial protocol Tekijä Christopher D Byrne, Tina Reinson, Hazel Woodland, Scott Harris, Karen Malone, Keith Cooper, Chinonso Nwoguh, Josh Bilson, Ryan M Buchanan

    Julkaistu 2025-03-01
    Hae kokoteksti
    Artikkeli
  16. 16
    Growth differentiation factor-15 and the association between type 2 diabetes and liver fibrosis in NAFLD

    Growth differentiation factor-15 and the association between type 2 diabetes and liver fibrosis in NAFLD Tekijä Josh Bilson, Eleonora Scorletti, Laure B. Bindels, Paul R. Afolabi, Giovanni Targher, Philip C. Calder, Jaswinder K. Sethi, Christopher D. Byrne

    Julkaistu 2021-10-01
    Hae kokoteksti
    Artikkeli
  17. 17
    Glycemic status, insulin resistance, and mortality from lung cancer among individuals with and without diabetes

    Glycemic status, insulin resistance, and mortality from lung cancer among individuals with and without diabetes Tekijä In Young Cho, Yoosoo Chang, Eunju Sung, Boyoung Park, Jae-Heon Kang, Hocheol Shin, Sarah H. Wild, Christopher D. Byrne, Seungho Ryu

    Julkaistu 2024-06-01
    Hae kokoteksti
    Artikkeli
  18. 18
    Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes.

    Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes. Tekijä Giovanni Targher, Filippo Valbusa, Stefano Bonapace, Lorenzo Bertolini, Luciano Zenari, Stefano Rodella, Giacomo Zoppini, William Mantovani, Enrico Barbieri, Christopher D Byrne

    Julkaistu 2013-01-01
    Hae kokoteksti
    Artikkeli
  19. 19
    Urine Albumin/Creatinine Ratio Below 30 mg/g is a Predictor of Incident Hypertension and Cardiovascular Mortality

    Urine Albumin/Creatinine Ratio Below 30 mg/g is a Predictor of Incident Hypertension and Cardiovascular Mortality Tekijä Ki‐Chul Sung, Seungho Ryu, Jong‐Young Lee, Sung Ho Lee, EunSun Cheong, Young‐Youl Hyun, Kyu‐Beck Lee, Hyang Kim, Christopher D. Byrne

    Julkaistu 2016-09-01
    Hae kokoteksti
    Artikkeli
  20. 20
    Liver fat: a relevant target for dietary intervention? Summary of a Unilever workshop

    Liver fat: a relevant target for dietary intervention? Summary of a Unilever workshop Tekijä Harry P. F. Peters, Patrick Schrauwen, Petra Verhoef, Christopher D. Byrne, David J. Mela, Andreas F. H. Pfeiffer, Ulf Risérus, Frits R. Rosendaal, Vera Schrauwen-Hinderling

    Julkaistu 2017-01-01
    Hae kokoteksti
    Artikkeli

Työkalut: